South Baltic ClinTrial Network is a special interest group, consisting of clinical trial centers of university hospitals, practices with clinical trial units, and SME service provider for (pre)clinical services from Germany, Poland, and Lithuania (project partners in the EU South Baltic Region project Eco4Life), collaborating with institutions from the Northern Baltic Sea.
The aim of the South Baltic ClinTrial Network is to develop tools and a common transregional approach for the conduct of international clinical trials in the whole Baltic Sea Region, according to the policy of the ScanBalt flagship project "Baltic Sea Health Region" as part of the EU Baltic Sea Strategy.

ScanBalt is a leading network of clusters, universities, companies and public authorities working within life sciences to promote the Baltic Sea Region as a globally competitive Green Valley and Health region. In 2013, the “Clinical Research Working Group” of Scanbalt was formed, with the South Baltic ClinTrail  Network as founding member. The South Baltic ClinTrial Network is coordinated by BioCon Valley®, the central contact for life science and health economy in North Eastern Germany (Mecklenburg-Vorpommern). The federal state is closely linked to emerging health economies in Poland and the Baltics, as well as to the dynamic Medtech region in the North of the Baltic Sea.

Mecklenburg-Vorpommern  with its expertise in community medicine (Univerisity Greifswald) and disease prevention (Univeristy Rostock, Univeristy of Applied Sciences Neubrandenburg) is supposed to become pilot region for personalized medicine, including the emerging topic of gender medicine. Within the initiative, partners intend to develop common approaches for the conduct of clinical trials and for patient recruitment, including  pediatriac and orphan indications (“Baltic Apheresis Working Group”).